NCT03730779撤回4 期
Normobaric Nocturnal Hyperoxia Therapy for Treating Ischemic-Related Retinal Conditions
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- Macula Edema
研究概览
简要总结
The investigators will be using nocturnal normobaric hyperoxia therapy in patients with diagnoses of conditions related to retinal ischemia.
详细描述
Patients who receive a diagnosis of a condition relate to retinal ischemia and who pass the eligibility criteria will receive an oxygen concentrator to use at home. They will report back in follow up monthly for three to six months.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of retinal-ischemia related condition
排除标准
- •Complicating other ocular condition
- •History of smoking or lung conditions
研究组 & 干预措施
O2 recieving
Experimental
Patients who receive hyperoxia
干预措施: Hyperoxia (Drug)
结局指标
主要结局
Macula Edema
时间窗: 6 months
Amount of ME present, as measured by OCT
Best Corrected Visual Acuity
时间窗: 6 months
Best Corrected Visual Acuity as measured by ETDRS chart
次要结局
未报告次要终点
研究者
Jorge Arroyo
Associate Professor of Ophthalmology
Beth Israel Deaconess Medical Center
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)Acute Ischemic StrokeNCT05965687Ji Xunming,MD,PhD1,230
招募中
3 期
Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke：Longterm Outcome (OPENS-3L)Acute Ischemic StrokeNCT05965193Ji Xunming,MD,PhD1,230
终止
4 期
Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 PatientsCOVID, CoronavirusNCT04409886Maimonides Medical Center1
已完成
4 期
Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Breathing and SleepChronic Obstructive Pulmonary Disease (COPD)NCT02150590University of Zurich32
已完成
4 期
Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Exercise PerformanceChronic Obstructive Pulmonary Disease (COPD)NCT02143609University of Zurich32